Black Opal Consultants, founded in 2020, is one of the leading real estate companies that partners with real estate developers such as Gaurs Group, SKA, Galaxy, Shapoorji Pallonji, Max Estates, and M3M to market and sell their residential and commercial projects. Its service offerings include Consulting & Advisory Services, Exclusive Sale Arrangements, Loan Syndication Services, and Real Estate Development.
Market Dashboard
Black Opal Consultants
ListedSMEBook Building Issue
Issue Price
₹185 to ₹197Face Value
₹10 Per Equity ShareIssue Size
Approx ₹55.08 CroresListing On
BSENSE
Scheduled
Allotment Status Being Checked
The scheduled allotment date has passed, but the result has not yet been detected. IPO Chowk will continue checking during the monitoring window.
Allotment date: 05 October 2026
Grey Market
₹78
+39.59% Est. Listing Premium
Est. Listing Price₹275
Updated: 03 Oct 2026, 10:43
About Black Opal Consultants IPO
Financial Health
Live Subscriptions
Tracking
Frequently Asked Questions
The public subscription window officially opens on 29 September 2026 and concludes at 5:00 PM IST on 01 October 2026.
As of the latest market information, the GMP is ₹78, indicating a 39.59% estimated listing premium. GMP is an unofficial market indicator and can change rapidly.
Shares are offered at ₹185 to ₹197. Retail investors must bid for at least 1200 shares, requiring a block investment of ₹2,36,400.
The allotment is scheduled for 05 October 2026. IPO Chowk automatically checks the registrar status and updates this page when the official allotment becomes available. Shares are scheduled to debut on the exchanges on 07 October 2026.
The registrar for this IPO is Skyline Financial Services Pvt.Ltd..
The issue size for Black Opal Consultants is Approx ₹55.08 Crores.
The current status of the Black Opal Consultants IPO is Listed. This status is determined from the issue and listing timeline using Indian Standard Time.
No. GMP is unofficial and can move significantly before listing. The actual listing price may differ from the GMP-based estimate.